GlassScriptPhysician profile
Shoeb A Mohiuddin
NPI 1770928640
$10,070.87
in general payments reported to CMS, 2019-2025
24 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,233 · 2020: $1,049 · 2021: $765 · 2022: $1,207 · 2023: $2,304 · 2024: $1,310 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,817.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,018.14 | 2022-2024 | Senza |
| Medtronic USA, INC. | $1,336.36 | 2019-2020 | |
| Abbott Laboratories | $1,307.13 | 2019-2023 | Proclaim |
| Globus Medical, INC. | $1,079.95 | 2025 | Senza, Vyrsa V1, Vyrsa V1 |
| Nalu Medical, INC. | $850.20 | 2020-2025 | Nalu Neurostimulation System |
| Electronic Waveform Lab, INC. | $726.73 | 2023-2024 | |
| Pacira Therapeutics, INC. | $361.88 | 2020-2021 | |
| Boston Scientific Corporation | $228.37 | 2019-2020 | |
| Medtronic, INC. | $227.56 | 2021-2022 | |
| Mml US, INC. | $162.16 | 2024 | Reactiv8 |
| Foundation Fusion Solutions, LLC | $148.21 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $121.25 | 2019 | |
| Spr Therapeutics, INC | $119.89 | 2023 | Sprint Pns System |
| Si-Bone, INC. | $97.17 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $60.12 | 2025 | Exparel |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $57.44 | 2023-2025 | |
| Biodelivery Sciences International, INC. | $36.85 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $21.50 | 2025 | |
| Bioventus LLC | $21.44 | 2020 | |
| Painteq LLC | $21.04 | 2024 | Painteq |
| Zyla Life Sciences, INC. | $18.49 | 2020 | |
| Collegium Pharmaceutical, INC. | $17.83 | 2019 | |
| Glaxosmithkline, LLC. | $15.74 | 2024 | Pediarix, Bexsero, Rotarix |
| Redhill Biopharma INC. | $15.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shoeb Mohiuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.